CNTM.F Stock Overview
Through its subsidiaries, produces and sells medical cannabis in Florida, Pennsylvania, and Texas.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Cansortium Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.15 |
| 52 Week High | US$0.29 |
| 52 Week Low | US$0.08 |
| Beta | 3.08 |
| 11 Month Change | -6.25% |
| 3 Month Change | 43.49% |
| 1 Year Change | 76.47% |
| 33 Year Change | -78.83% |
| 5 Year Change | -73.21% |
| Change since IPO | -91.57% |
Recent News & Updates
Recent updates
Shareholder Returns
| CNTM.F | US Pharmaceuticals | US Market | |
|---|---|---|---|
| 7D | -13.5% | -3.7% | -1.6% |
| 1Y | 76.5% | 17.2% | 30.8% |
Return vs Industry: CNTM.F exceeded the US Pharmaceuticals industry which returned 17.2% over the past year.
Return vs Market: CNTM.F exceeded the US Market which returned 30.8% over the past year.
Price Volatility
| CNTM.F volatility | |
|---|---|
| CNTM.F Average Weekly Movement | 12.2% |
| Pharmaceuticals Industry Average Movement | 9.3% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 14.9% |
| 10% least volatile stocks in US Market | 2.9% |
Stable Share Price: CNTM.F's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: CNTM.F's weekly volatility (12%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2018 | n/a | Robert Beasley | getfluent.com |
Cansortium Inc., through its subsidiaries, produces and sells medical cannabis in Florida, Pennsylvania, and Texas. The company’s medical cannabis products are offered in oral drops, capsules, topicals, syringes, dried flower, pre-rolls, cartridges, concentrates, and edibles under the Fluent brand name. It also sells various third-party branded medical cannabis products.
Cansortium Inc. Fundamentals Summary
| CNTM.F fundamental statistics | |
|---|---|
| Market cap | US$45.28m |
| Earnings (TTM) | -US$13.23m |
| Revenue (TTM) | US$103.30m |
0.4x
P/S Ratio-3.4x
P/E RatioIs CNTM.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CNTM.F income statement (TTM) | |
|---|---|
| Revenue | US$103.30m |
| Cost of Revenue | US$40.24m |
| Gross Profit | US$63.06m |
| Other Expenses | US$76.29m |
| Earnings | -US$13.23m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.044 |
| Gross Margin | 61.04% |
| Net Profit Margin | -12.81% |
| Debt/Equity Ratio | 1,174.6% |
How did CNTM.F perform over the long term?
See historical performance and comparison